Position
Squarepoint Ops LLC in Neogenomics Inc
Back to the book · All holders of NEO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$140.2K$11.76 → $7.42
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 32.3K | $380K | — | — | — | 0.0% |
| Q1 2026 | 101.7K | $754.6K | $7.42 | −$140.2K | $514.8K | 0.0% |